205 related articles for article (PubMed ID: 34212451)
1. Muscarinic acetylcholine receptor M1 mutations causing neurodevelopmental disorder and epilepsy.
Marcé-Grau A; Elorza-Vidal X; Pérez-Rius C; Ruiz-Nel Lo A; Sala-Coromina J; Gabau E; Estévez R; Macaya A
Hum Mutat; 2021 Oct; 42(10):1215-1220. PubMed ID: 34212451
[TBL] [Abstract][Full Text] [Related]
2. De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy.
Usmani MA; Ahmed ZM; Magini P; Pienkowski VM; Rasmussen KJ; Hernan R; Rasheed F; Hussain M; Shahzad M; Lanpher BC; Niu Z; Lim FY; Pippucci T; Ploski R; Kraus V; Matuszewska K; Palombo F; Kianmahd J; ; Martinez-Agosto JA; Lee H; Colao E; Motazacker MM; Brigatti KW; Puffenberger EG; Riazuddin SA; Gonzaga-Jauregui C; Chung WK; Wagner M; Schultz MJ; Seri M; Kievit AJA; Perrotti N; Wassink-Ruiter JSK; van Bokhoven H; Riazuddin S; Riazuddin S
Am J Hum Genet; 2021 Jul; 108(7):1330-1341. PubMed ID: 34102099
[TBL] [Abstract][Full Text] [Related]
3. Monoallelic and bi-allelic variants in NCDN cause neurodevelopmental delay, intellectual disability, and epilepsy.
Fatima A; Hoeber J; Schuster J; Koshimizu E; Maya-Gonzalez C; Keren B; Mignot C; Akram T; Ali Z; Miyatake S; Tanigawa J; Koike T; Kato M; Murakami Y; Abdullah U; Ali MA; Fadoul R; Laan L; Castillejo-López C; Liik M; Jin Z; Birnir B; Matsumoto N; Baig SM; Klar J; Dahl N
Am J Hum Genet; 2021 Apr; 108(4):739-748. PubMed ID: 33711248
[TBL] [Abstract][Full Text] [Related]
4. De novo variants in SP9 cause a novel form of interneuronopathy characterized by intellectual disability, autism spectrum disorder, and epilepsy with variable expressivity.
Tessarech M; Friocourt G; Marguet F; Lecointre M; Le Mao M; Díaz RM; Mignot C; Keren B; Héron B; De Bie C; Van Gassen K; Loisel D; Delorme B; Syrbe S; Klabunde-Cherwon A; Jamra RA; Wegler M; Callewaert B; Dheedene A; Zidane-Marinnes M; Guichet A; Bris C; Van Bogaert P; Biquard F; Lenaers G; Marcorelles P; Ferec C; Gonzalez B; Procaccio V; Vitobello A; Bonneau D; Laquerriere A; Khiati S; Colin E
Genet Med; 2024 May; 26(5):101087. PubMed ID: 38288683
[TBL] [Abstract][Full Text] [Related]
5. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
6. Whole exome sequencing reveals de novo pathogenic variants in KAT6A as a cause of a neurodevelopmental disorder.
Millan F; Cho MT; Retterer K; Monaghan KG; Bai R; Vitazka P; Everman DB; Smith B; Angle B; Roberts V; Immken L; Nagakura H; DiFazio M; Sherr E; Haverfield E; Friedman B; Telegrafi A; Juusola J; Chung WK; Bale S
Am J Med Genet A; 2016 Jul; 170(7):1791-8. PubMed ID: 27133397
[TBL] [Abstract][Full Text] [Related]
7. De novo variants in CNOT9 cause a neurodevelopmental disorder with or without epilepsy.
von Wintzingerode L; Ben-Zeev B; Cesario C; Chan KM; Depienne C; Elpeleg O; Iascone M; Kelley WV; Nassogne MC; Niceta M; Pezzani L; Rahner N; Revencu N; Bekheirnia MR; Santiago-Sim T; Tartaglia M; Thompson ML; Trivisano M; Hentschel J; Sticht H; Abou Jamra R; Oppermann H
Genet Med; 2023 Jul; 25(7):100859. PubMed ID: 37092538
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the genetic basis of comorbid epilepsy phenotypes in neurodevelopmental disorders.
Chow J; Jensen M; Amini H; Hormozdiari F; Penn O; Shifman S; Girirajan S; Hormozdiari F
Genome Med; 2019 Oct; 11(1):65. PubMed ID: 31653223
[TBL] [Abstract][Full Text] [Related]
9. De novo missense variants in the E3 ubiquitin ligase adaptor KLHL20 cause a developmental disorder with intellectual disability, epilepsy, and autism spectrum disorder.
Sleyp Y; Valenzuela I; Accogli A; Ballon K; Ben-Zeev B; Berkovic SF; Broly M; Callaerts P; Caylor RC; Charles P; Chatron N; Cohen L; Coppola A; Cordeiro D; Cuccurullo C; Cuscó I; Janette diMonda ; Duran-Romaña R; Ekhilevitch N; Fernández-Alvarez P; Gordon CT; Isidor B; Keren B; Lesca G; Maljaars J; Mercimek-Andrews S; Morrow MM; Muir AM; ; Rousseau F; Salpietro V; Scheffer IE; Schnur RE; Schymkowitz J; Souche E; Steyaert J; Stolerman ES; Vengoechea J; Ville D; Washington C; Weiss K; Zaid R; Sadleir LG; Mefford HC; Peeters H
Genet Med; 2022 Dec; 24(12):2464-2474. PubMed ID: 36214804
[TBL] [Abstract][Full Text] [Related]
10. Further evidence for de novo variants in SYNCRIP as the cause of a neurodevelopmental disorder.
Semino F; Schröter J; Willemsen MH; Bast T; Biskup S; Beck-Woedl S; Brennenstuhl H; Schaaf CP; Kölker S; Hoffmann GF; Haack TB; Syrbe S
Hum Mutat; 2021 Sep; 42(9):1094-1100. PubMed ID: 34157790
[TBL] [Abstract][Full Text] [Related]
11. A novel
Qiu T; Dai Q; Wang Q
J Int Med Res; 2021 Nov; 49(11):3000605211058372. PubMed ID: 34851771
[No Abstract] [Full Text] [Related]
12. Brief Report: SETD2 Mutation in a Child with Autism, Intellectual Disabilities and Epilepsy.
Lumish HS; Wynn J; Devinsky O; Chung WK
J Autism Dev Disord; 2015 Nov; 45(11):3764-70. PubMed ID: 26084711
[TBL] [Abstract][Full Text] [Related]
13. De novo variants of NR4A2 are associated with neurodevelopmental disorder and epilepsy.
Singh S; Gupta A; Zech M; Sigafoos AN; Clark KJ; Dincer Y; Wagner M; Humberson JB; Green S; van Gassen K; Brandt T; Schnur RE; Millan F; Si Y; Mall V; Winkelmann J; Gavrilova RH; Klee EW; Engleman K; Safina NP; Slaugh R; Bryant EM; Tan WH; Granadillo J; Misra SN; Schaefer GB; Towner S; Brilstra EH; Koeleman BPC
Genet Med; 2020 Aug; 22(8):1413-1417. PubMed ID: 32366965
[TBL] [Abstract][Full Text] [Related]
14. De Novo Missense Variants in SLC32A1 Cause a Developmental and Epileptic Encephalopathy Due to Impaired GABAergic Neurotransmission.
Platzer K; Sticht H; Bupp C; Ganapathi M; Pereira EM; Le Guyader G; Bilan F; Henderson LB; Lemke JR; Taschenberger H; Brose N; Abou Jamra R; Wojcik SM
Ann Neurol; 2022 Dec; 92(6):958-973. PubMed ID: 36073542
[TBL] [Abstract][Full Text] [Related]
15. De novo MCM6 variants in neurodevelopmental disorders: a recognizable phenotype related to zinc binding residues.
Smits DJ; Schot R; Popescu CA; Dias KR; Ades L; Briere LC; Sweetser DA; Kushima I; Aleksic B; Khan S; Karageorgou V; Ordonez N; Sleutels FJGT; van der Kaay DCM; Van Mol C; Van Esch H; Bertoli-Avella AM; Roscioli T; Mancini GMS
Hum Genet; 2023 Jul; 142(7):949-964. PubMed ID: 37198333
[TBL] [Abstract][Full Text] [Related]
16. De novo ARHGEF9 missense variants associated with neurodevelopmental disorder in females: expanding the genotypic and phenotypic spectrum of ARHGEF9 disease in females.
Scala M; Zonneveld-Huijssoon E; Brienza M; Mecarelli O; van der Hout AH; Zambrelli E; Turner K; Zara F; Peron A; Vignoli A; Striano P
Neurogenetics; 2021 Mar; 22(1):87-94. PubMed ID: 32939676
[TBL] [Abstract][Full Text] [Related]
17. Distinct genetic patterns of shared and unique genes across four neurodevelopmental disorders.
Zhang Y; Wang R; Liu Z; Jiang S; Du L; Qiu K; Li F; Wang Q; Jin J; Chen X; Li Z; Wu J; Zhang N
Am J Med Genet B Neuropsychiatr Genet; 2021 Jan; 186(1):3-15. PubMed ID: 32929885
[TBL] [Abstract][Full Text] [Related]
18. Delineating SPTAN1 associated phenotypes: from isolated epilepsy to encephalopathy with progressive brain atrophy.
Syrbe S; Harms FL; Parrini E; Montomoli M; Mütze U; Helbig KL; Polster T; Albrecht B; Bernbeck U; van Binsbergen E; Biskup S; Burglen L; Denecke J; Heron B; Heyne HO; Hoffmann GF; Hornemann F; Matsushige T; Matsuura R; Kato M; Korenke GC; Kuechler A; Lämmer C; Merkenschlager A; Mignot C; Ruf S; Nakashima M; Saitsu H; Stamberger H; Pisano T; Tohyama J; Weckhuysen S; Werckx W; Wickert J; Mari F; Verbeek NE; Møller RS; Koeleman B; Matsumoto N; Dobyns WB; Battaglia D; Lemke JR; Kutsche K; Guerrini R
Brain; 2017 Sep; 140(9):2322-2336. PubMed ID: 29050398
[TBL] [Abstract][Full Text] [Related]
19. De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures.
Myers CT; Stong N; Mountier EI; Helbig KL; Freytag S; Sullivan JE; Ben Zeev B; Nissenkorn A; Tzadok M; Heimer G; Shinde DN; Rezazadeh A; Regan BM; Oliver KL; Ernst ME; Lippa NC; Mulhern MS; Ren Z; Poduri A; Andrade DM; Bird LM; Bahlo M; Berkovic SF; Lowenstein DH; Scheffer IE; Sadleir LG; Goldstein DB; Mefford HC; Heinzen EL
Am J Hum Genet; 2017 Oct; 101(4):516-524. PubMed ID: 28942967
[TBL] [Abstract][Full Text] [Related]
20. Targeted sequencing identifies risk variants in 202 candidate genes for neurodevelopmental disorders.
Pang N; Li K; Tan S; Chen M; He F; Chen C; Yang L; Zhang C; Deng X; Yang L; Mao L; Wang G; Duan H; Wang X; Zhang W; Guo H; Peng J; Yin F; Xia K
Gene; 2024 Mar; 897():148071. PubMed ID: 38081334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
